Enfermedad de Alzheimer: Actualización en terapia farmacológica

Dementia in general, especially Alzheimer disease and vascular dementia, are diseases of high prevalence with severe socio-economic consequences in all countries. In recent years, due to the obtention of new pharmaceutical products acting on different brain neurotransmitters, there has been importan...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fuentes G,Patricio, Slachevsky Ch,Andrea
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2005
Materias:	Alzheimer disease Dementia Neurotransmitters
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200012
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872005000200012
record_format	dspace
spelling	oai:scielo:S0034-988720050002000122005-04-12Enfermedad de Alzheimer: Actualización en terapia farmacológicaFuentes G,PatricioSlachevsky Ch,Andrea Alzheimer disease Dementia Neurotransmitters Dementia in general, especially Alzheimer disease and vascular dementia, are diseases of high prevalence with severe socio-economic consequences in all countries. In recent years, due to the obtention of new pharmaceutical products acting on different brain neurotransmitters, there has been important changes in the therapy of these diseases. Although these drugs do not stop disease progression, there is consistent evidence of their usefulness in cognitive, behavioral and functional domains and of their pharmaco-economical justification. This article reviews the main drugs available for Alzheimer disease and some future therapeutic perspectives (Rev Méd Chil 2005; 133: 224-30)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.2 20052005-02-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200012es10.4067/S0034-98872005000200012
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Alzheimer disease Dementia Neurotransmitters
spellingShingle	Alzheimer disease Dementia Neurotransmitters Fuentes G,Patricio Slachevsky Ch,Andrea Enfermedad de Alzheimer: Actualización en terapia farmacológica
description	Dementia in general, especially Alzheimer disease and vascular dementia, are diseases of high prevalence with severe socio-economic consequences in all countries. In recent years, due to the obtention of new pharmaceutical products acting on different brain neurotransmitters, there has been important changes in the therapy of these diseases. Although these drugs do not stop disease progression, there is consistent evidence of their usefulness in cognitive, behavioral and functional domains and of their pharmaco-economical justification. This article reviews the main drugs available for Alzheimer disease and some future therapeutic perspectives (Rev Méd Chil 2005; 133: 224-30)
author	Fuentes G,Patricio Slachevsky Ch,Andrea
author_facet	Fuentes G,Patricio Slachevsky Ch,Andrea
author_sort	Fuentes G,Patricio
title	Enfermedad de Alzheimer: Actualización en terapia farmacológica
title_short	Enfermedad de Alzheimer: Actualización en terapia farmacológica
title_full	Enfermedad de Alzheimer: Actualización en terapia farmacológica
title_fullStr	Enfermedad de Alzheimer: Actualización en terapia farmacológica
title_full_unstemmed	Enfermedad de Alzheimer: Actualización en terapia farmacológica
title_sort	enfermedad de alzheimer: actualización en terapia farmacológica
publisher	Sociedad Médica de Santiago
publishDate	2005
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000200012
work_keys_str_mv	AT fuentesgpatricio enfermedaddealzheimeractualizacionenterapiafarmacologica AT slachevskychandrea enfermedaddealzheimeractualizacionenterapiafarmacologica
_version_	1718436191259328512

Enfermedad de Alzheimer: Actualización en terapia farmacológica

Ejemplares similares